Notably, the expression levels of SMURF2, quantified in IHCs as SMURF2 staining intensity, were comparable between normal and PRAD samples, though some reduction in the percentage of SMURF2-positive cells was recorded in cancer (Figure 3c). The gene discussed is SMURF2; the disease is cancer.